Despite the limitations provided by the species difference, these cancer cell lines are very well‐established and have been studied extensively in mouse models of cancer cell metastasis.[29, 30] A key limitation of the MLO‐Y4 cell line is low sclerostin expression, which prevents us from investigating the effect of this pathway in bone metastasis. The gene discussed is SOST; the disease is cancer.